an effective, fast-acting, and generally safe non-invasive treatment for controlling mild to moderate hemoptysis (coughing up blood) by promoting localized clot formation in the airways. Common dosages include
to
administered via nebulizer 3–4 times daily.
- Uses: Primarily used for hemoptysis (pulmonary hemorrhage) and, in some cases, epistaxis. It is particularly useful for patients needing to continue systemic anticoagulation who have localized bleeding.
- Effectiveness: Studies show rapid bleeding cessation (within 15 minutes) and reduced need for invasive procedures, with one trial showing 96% of patients achieving complete resolution within five days
Administration: It can be administered by mixing the standard
intravenous (IV) solution with normal saline.
- Vs. IV/Oral TXA: Nebulized delivery provides high local concentration in the lungs while minimizing systemic absorption, reducing the risk of thrombosis compared to systemic administration.
- Vs. Procedures: It acts as a rapid, less invasive alternative to bronchoscopy or angiography for initial management.
0 comments